March 15, 2018
Days after Thanksgiving, the FDA approved Foundation Medicine’s comprehensive genetic test for evaluating cancer. The idea—and practice—of testing tumors for specific DNA or protein abnormalities is not new. Previously, the agency listed several dozen approved companion diagnostic tests; these earlier tools check one or a few molecules to inform the cancer subtype, prognosis, and likelihood of response to treatments.
Source: Forbes
https://www.forbes.com/sites/elaineschattner/2018/03/06/all-cancer-patients-should-have-access-to-molecular-and-genomic-testing/#443f12443d48
